Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
The Journal of Biological Chemistry
|
August 14, 1999
Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase
S Ghosh, D Wolan, S Adak, et al.
Cancer
|
July 24, 2001
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck
A D Colevas, P C Amrein, H Gomolin, et al.
The New England Journal of Medicine
|
November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group
S M Keller, S Adak, H Wagner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer
S M Keller, M G Vangel, S Adak, et al.
American Journal of Clinical Oncology
|
April 11, 2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)
A D Colevas, C M Norris, R B Tishler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy
J H Schiller, S Adak, R H Feins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
A D Colevas, C M Norris, R B Tishler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial
A D Colevas, P M Busse, C M Norris, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
The Journal of Biological Chemistry
|
August 14, 1999
Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase
S Ghosh, D Wolan, S Adak, et al.
Cancer
|
July 24, 2001
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck
A D Colevas, P C Amrein, H Gomolin, et al.
The New England Journal of Medicine
|
November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group
S M Keller, S Adak, H Wagner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer
S M Keller, M G Vangel, S Adak, et al.
American Journal of Clinical Oncology
|
April 11, 2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)
A D Colevas, C M Norris, R B Tishler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy
J H Schiller, S Adak, R H Feins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
A D Colevas, C M Norris, R B Tishler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial
A D Colevas, P M Busse, C M Norris, et al.
Page
of 4